ALS patient Brad Smith controls computers with thoughts using Neuralink's brain chip, bypassing eye-tracking limitations for ...

One ALS patient received TRE-515 under the FDA program last year, and early signs suggest the therapy may help stabilize ...

The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve ...

ALS patients and caregivers prefer care models where multiple specialists are seen during the same visit. They prioritize team-based care and ALS expertise over factors like visit length or cost.

For almost a decade, I’ve fought for a cure for a disease I don’t even have yet. In 2018, when my mom was dying of the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), I learned ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...

(NewsNation) — Scientists have discovered what the immune system attacks in people with ALS, a breakthrough that could lead to new treatments for the fatal disease. The study, published Wednesday in ...

Eric Dane not only battled ALS, but also advocated for others fighting the disease before his death. Dane’s work as an ALS ...

Cheryl Fleming never expected to become ill with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Amyotrophic lateral sclerosis, or ALS, is a progressive disease that attacks the brain and spinal cord, robbing people of ...